The advent of two new classes of glucose-lowering drugs (GLDs), the sodium-glucose cotransporter-2 inhibitors (SGLT2is) and the glucagon-like peptide-1 receptor agonists (GLP-1RAs), has led to a paradigm shift in type 2 diabetes treatment [3] since these drugs may reduce CVD risk and mortality effectively [4,5,6]
Not the right fit for users who need appetite-friendly portions or are sensitive to bland flavors
These GLP-1 and dual GIP/GLP-1 receptor agonists work by reducing appetite, slowing digestion, and improving metabolic function
Enjoy the episode
Packed with Amino Acids , Methylated B12 , ALA (Alpha-Lipoic Acid), and a Multi-Vita Blend , this infusion aids mental clarity, energy restoration, neurotransmitter support, and overall reboothelping you shake off jet lag and regain focus quickly